Suppr超能文献

丁螺环酮及其主要代谢产物1-(2-嘧啶基)-哌嗪(1-PP)对大鼠抗冲突作用的比较。

Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats.

作者信息

Amano M, Goto A, Sakai A, Achiha M, Takahashi N, Hara C, Ogawa N

机构信息

Pharmacology Laboratory, Bristol-Myers Squibb K.K., Aichi, Japan.

出版信息

Jpn J Pharmacol. 1993 Apr;61(4):311-7. doi: 10.1254/jjp.61.311.

Abstract

The anxiolytic effects of buspirone and its major metabolite, 1-(2-pyrimidinyl)-piperazine (1-PP) have been investigated with a conflict (shock-induced suppression of drinking) paradigm in rats. Buspirone (10 mg/kg, p.o.) showed an anticonflict activity with a bell-shaped dose-response relationship without any effect on spontaneous water consumption. Higher doses of buspirone reduced the punished response. Diazepam (20 and 40 mg/kg, p.o.) also showed an anticonflict activity in a dose-dependent manner, but animals with diazepam showed an increase in spontaneous water consumption at these doses. On the other hand, 1-PP (6.25-200 mg/kg, p.o.) showed a weak anticonflict activity with a significant effect at 25 mg/kg without any effect on spontaneous water consumption. In the 7-day treatment test, buspirone (5 and 10 mg/kg, p.o.), 1-PP (5 and 25 mg/kg, p.o.) and diazepam (10 and 40 mg/kg, p.o.) did not develop the tolerance to the anticonflict activity. Conversely, the anticonflict activity of diazepam was increased by the repeated treatment. Diazepam (10 mg/kg, p.o.) showed an anticonflict activity without any effect on spontaneous water consumption in this test. These results demonstrated that buspirone clearly exhibited an anticonflict effect similar to that of diazepam in a Vogel-type conflict test, and its real anxiolytic effect may not be always based on 1-PP, the main metabolite of buspirone.

摘要

已采用冲突(电击诱导饮水抑制)范式在大鼠中研究了丁螺环酮及其主要代谢物1-(2-嘧啶基)-哌嗪(1-PP)的抗焦虑作用。丁螺环酮(10毫克/千克,口服)呈现出抗冲突活性,具有钟形剂量-反应关系,对自发饮水无任何影响。更高剂量的丁螺环酮可降低受罚反应。地西泮(20和40毫克/千克,口服)也以剂量依赖性方式呈现抗冲突活性,但接受地西泮的动物在这些剂量下自发饮水增加。另一方面,1-PP(6.25 - 200毫克/千克,口服)呈现出较弱的抗冲突活性,在25毫克/千克时有显著作用,对自发饮水无任何影响。在为期7天的治疗试验中,丁螺环酮(5和10毫克/千克,口服)、1-PP(5和25毫克/千克,口服)和地西泮(10和40毫克/千克,口服)未产生抗冲突活性的耐受性。相反,地西泮的抗冲突活性通过重复治疗而增强。地西泮(10毫克/千克,口服)在该试验中呈现出抗冲突活性,对自发饮水无任何影响。这些结果表明,在Vogel型冲突试验中,丁螺环酮明显表现出与地西泮相似的抗冲突作用,其真正的抗焦虑作用可能并不总是基于丁螺环酮的主要代谢物1-PP。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验